#ECO2021 is a learning platform for disseminating the best obesity research and practice in Europe, and a tool for discussion, collaboration and sharing. We will offer plenary discussion sessions, teaching workshops, case study discussions and moderated e-poster sessions. ECO2021 has received CME accreditation by the EACCME®. Visit the congress website for details.
Programme topics will be organised into four main areas:
Day 1: Basic Science
Day 2: Childhood and Adolescent Obesity
Day 3: Behavioural and Public Health
Day 4: Management and Intervention
You will have the opportunity to learn from and speak with members of the European Coalition for People Living with Obesity (ECPO), who are integral to the congress. Register today!
7th CANADIAN OBESITY SUMMIT & ECO2021 WILL RUN CONCURRENTLY ONLINE
Obesity Canada (OC) and EASO will offer our virtual flagship scientific conferences simultaneously 10-13 May, 2021. Joint sessions will be held at the end of each day for #ECO2021 to jumpstart the day for the Canadian Obesity Summit.
FEATURED ARTICLES THIS MONTH
VACCINATING PEOPLE WITH OBESITY FOR COVID-19:
EASO POSITION STATEMENT AND CALL FOR ACTION
We are pleased to share the new EASO Call to Action on vaccination for people with obesity.
Read the full statement in Obesity Facts, the European Journal of Obesity:
MEP Interest Group on Obesity and Resilient Health Systems
As demonstrated within the EU4Health programme, the European Parliament can play a key role in promoting actions impacting the long-term health of EU citizens and strengthening health systems for the future.
This new interest group, chaired by MEP Pernille Weiss (EPP, Denmark), focuses on implementing obesity as a chronic non-communicable disease (NCD). The ambition of the group is to ensure obesity is recognised as a chronic disease in definition, scope, and in the way it is addressed within policy instruments. Crucially, the group will go beyond obesity to consider developing more resilient health systems and ecosystems more broadly. Click here to read the press release
TALKING ABOUT WEIGHT: A GUIDE FOR GPS AND HEALTH CARE PROFESSIONALS
We are pleased to share this excellent infographic developed by Dr Michael Crotty, providing guidance and support to physicians and other HCPs in General Practice around understanding and communicating with patients about unhealthy excess weight.
Click here to learn more
NOT TO BE MISSED
EASO represents the European Obesity Community
- EASO develops and supports active campaign groups
- We support our national members
- EASO provides a global platform for sharing ideas and developing solutions in the European context
- We support development of a unified evidence-based approach to addressing obesity across disciplines and countries
- We advocate around obesity as an urgent and relevant health priority to policymakers, NGOs, research funders, health professionals, media, industry and the public, and
- Identify and articulate effective solutions to these stakeholders
COVID-19 AND OBESITY
READ RECENT ARTICLES HERE
READ THE LATEST EDUCATION ARTICLES HERE
OBESITY FACTS JOURNAL
The latest edition of Obesity Facts, the European Journal of Obesity, Volume 14 number 2, Karger Publishers, is now available, online and open access.
Read about micronutrient deficiency following bariatric surgery, VLCKD recommendations, basic science studies, and behavioural research.
EASO acts as a dissemination and communications partner in a number of important EU funded Horizon 2020 research projects, often as WP leader.
The PROTEIN Project is a research initiative led by a consortium of European public- and private-sector organisations working to promote health and wellbeing. Bringing together experts from across Europe, PROTEIN will develop tools using AI to provide personalised nutrition and physical activity support to people in the EU.
SWEET, a European Commission Horizon 2020 funded project, is supported by a consortium of 29 pan-European research, consumer and industry partners, who are reviewing and developing evidence on long term benefits and potential risks involved in switching over to sweeteners and sweetness enhancers (S&SEs) in the context of public health and safety, obesity, and sustainability.